Decentralized Trials STREAM

31. All In On DCT 11/29/2022

    Technology and clinical trials have gone hand in hand for a very long time. With an understanding of industry needs and an eye to the future, learn about the push to greater adoption of more innovations.

32. IRT And Direct-To-Patient Trials 1/12/2022

    Want to know more about the growth and expansion of IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study.

33. How Optimized Trials Enhance Patient Enrollment, Retention, And More 9/16/2024

    Watch as experts from Elligo discuss the benefits, challenges, and solutions associated with optimized trials. Discover how leveraging these strategies can solve key issues in clinical research.

34. Creating The Digital Foundation For Scale In Clinical Development 8/11/2023

    Learn how CROs, pharma, and biotechs are using digital trial methods to scale efficiencies across the entirety of their clinical trial portfolio for maximum ROI.

35. Elevating The Site Voice 3/27/2025

    A decentralized trial can be daunting for sites, but Medidata offers solutions to help site staff, sponsors, and patients move smoothly through the clinical trial process.

36. Applying The Lessons Of The Pandemic To Your Upcoming Trial 8/26/2022

    In this webinar featuring Ellen Weiss, vice president of in-home solutions for PCM Trials, learn how the pandemic has impacted the industry and what it means for CROs and sponsors now and moving forward.

37. A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data 2/25/2025

    Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.

38. Medable Total Consent: The Future Of Informed Consent 2/14/2023

    With Total Consent, Medable is transforming the consenting process – harmonizing it into one simple-to-use platform that enables trial sponsors and CROs to completely customize eConsent.

39. The Platform Shift is Here: Are you Realizing ROI Across your Portfolio of Studies? 9/20/2022

    Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.

40. Patient First Solutions For Oncology 2/14/2023

    Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.